111 related articles for article (PubMed ID: 16172230)
1. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism.
Starr JR; Chen C; Doody DR; Hsu L; Ricks S; Weiss NS; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2183-90. PubMed ID: 16172230
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
3. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.
Västermark Å; Giwercman YL; Hagströmer O; Rajpert De-Meyts E; Eberhard J; Ståhl O; Cedermark GC; Rastkhani H; Daugaard G; Arver S; Giwercman A
Eur J Cancer; 2011 Feb; 47(3):413-9. PubMed ID: 20880698
[TBL] [Abstract][Full Text] [Related]
6. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
[TBL] [Abstract][Full Text] [Related]
7. Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study.
Biggs ML; Davis MD; Eaton DL; Weiss NS; Barr DB; Doody DR; Fish S; Needham LL; Chen C; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2012-8. PubMed ID: 18708392
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer risk and polymorphisms involved in estrogen catabolism.
Holt SK; Rossing MA; Malone KE; Schwartz SM; Weiss NS; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):481-9. PubMed ID: 17372243
[TBL] [Abstract][Full Text] [Related]
10. An oncofetal and developmental perspective on testicular germ cell cancer.
Rijlaarsdam MA; Looijenga LH
Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
[TBL] [Abstract][Full Text] [Related]
11. Familial coaggregation of cryptorchidism, hypospadias, and testicular germ cell cancer: a nationwide cohort study.
Schnack TH; Poulsen G; Myrup C; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Feb; 102(3):187-92. PubMed ID: 20026812
[TBL] [Abstract][Full Text] [Related]
12. Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer?
Bang AK; Busch AS; Almstrup K; Gromoll J; Kliesch S; Rajpert-De Meyts E; Skakkebaek NE; Juul A; Tüttelmann F; Jørgensen N
Andrology; 2018 Jan; 6(1):176-183. PubMed ID: 29179257
[TBL] [Abstract][Full Text] [Related]
13. Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958-2007.
Kvammen O; Tretli S; Johannessen TB; Klepp O; Grotmol T
Acta Oncol; 2012 Feb; 51(2):177-84. PubMed ID: 22248063
[TBL] [Abstract][Full Text] [Related]
14. Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.
Al-Jebari Y; Glimelius I; Berglund Nord C; Cohn-Cedermark G; Ståhl O; Tandstad T; Jensen A; Sagstuen Haugnes H; Daugaard G; Rylander L; Giwercman A
PLoS Med; 2019 Jun; 16(6):e1002816. PubMed ID: 31163029
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer.
Brokken LJ; Lundberg-Giwercman Y; Rajpert De-Meyts E; Eberhard J; Ståhl O; Cohn-Cedermark G; Daugaard G; Arver S; Giwercman A
Mol Cell Endocrinol; 2012 Apr; 351(2):279-85. PubMed ID: 22245602
[TBL] [Abstract][Full Text] [Related]
16. Cotinine concentrations in maternal serum and amniotic fluid during pregnancy and risk of testicular germ cell cancer in the offspring: A prospective nested case-control study.
Beck AL; Uldbjerg CS; Lim YH; Coull BA; Sørensen KM; Utko MM; Wilkowski B; Rantakokko P; Bengtsson M; Lindh C; Petersen JH; Skakkebaek NE; Hauser R; Juul A; Bräuner EV
Int J Cancer; 2024 Jan; 154(1):71-80. PubMed ID: 37603038
[TBL] [Abstract][Full Text] [Related]
17. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
18. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
[TBL] [Abstract][Full Text] [Related]
20. Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts.
Li N; Hauser R; Holford T; Zhu Y; Zhang Y; Bassig BA; Honig S; Chen C; Boyle P; Dai M; Schwartz SM; Morey P; Sayward H; Hu Z; Shen H; Gomery P; Zheng T
Br J Cancer; 2015 Mar; 112(7):1247-50. PubMed ID: 25826226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
